• 1
    Daniels J, Kissane DW. Psychosocial interventions for cancer patients. Curr Opin Oncol 2008;20:367371.
  • 2
    Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry 2003;54:269282.
  • 3
    Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004;32:5771.
  • 4
    Sellick SM, Crooks DL. Depression and cancer: an appraisal of the literature for prevalence, detection and practice guideline development for psychological interventions. Psycho-Oncology 1999;8:315333.
  • 5
    Watson M, Homewood J, Haviland J, Bliss JM. Influence of psychological response on breast cancer survival: 10-year follow-up of a population-based cohort. Eur J Cancer Psycho-Oncol 2005;41(12):17101714.
  • 6
    Trask PC. Assessment of depression in cancer patients. J Natl Cancer Inst Monogr 2004;32:8092.
  • 7
    Glik ID. Adding psychotherapy to pharmacotherapy data, benefits and guidelines for integration. Am J Psychother 2004;58(2):186208.
  • 8
    Keller M, McCullough J, Klein D et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl Nedicine 2000;342:462470.
  • 9
    de Jonghe F, Kool S, van Aalst G, Dekker J, Peen J. Combining psychotherapy and antidepressants in the treatment of depression. J Affect Disord 2001;64:217229.
  • 10
    Hirschfeld RM, Dunner DL, Keitner G et al. Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy and their combination. Biol Psychiatry 2002;51:123133.
  • 11
    Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Combined pharmacotherapy and psychological treatment for depression. A systematic review. Arch Gen Psychiatry 2004;61:714719.
  • 12
    Rodin G, Lloyd N, Katz M, Green E, Mackay JA, Wong RK. The treatment of depression in cancer patients: a systematic review. Support Care Cancer 2007;15:123136.
  • 13
    Rodin G, Katz M, Lloyd N et al. Treatment of depression in cancer patients. Current Oncol 2007;14:180188.
  • 14
    Strong V, Waters R, Hibberd C et al. Management of depression for people with cancer (SMaRT oncology 1): a randomised trial. Lancet 2008;372:4048.
  • 15
    Ell K, Xie B, Quon B et al. Randomized controlled trial of collaborative care management of depression among low-income patients with cancer. J Clin Oncol 2008;26:44884496.
  • 16
    Newell SA, Sanson-Fisher RW, Savolainen NJ. Systematic review of psychological therapies for cancer patients: overview and recommendations for future research. J Natl Cancer Inst 2002;94:558584.
  • 17
    Scott M, Sellicka B, Crooksb D. Depression and cancer: an appraisal of the leterature for prevalence, detection and practice guideline development for psychological interventions. Psycho-Oncology 1999;8:315333.
  • 18
    Freedman J, Combs G. Narrative Therapy. Norton: New York, 1996.
  • 19
    Vromans LP. Process and outcome of Narrative therapy for Major Depressive Disorder in adults. Thesis, Quensland, 2007.
  • 20
    Kholer Riessman C. Narrative Methods for the Human Sciences. Sage: New York, 2008.
  • 21
    Breitbart W, Rosenfeld B, Gibson C et al. Meaning-centered group psychotherapy for patients with advanced cancer: a pilot randomized controlled trial. Psycho-Oncology 2010;19(1):2128.
  • 22
    Etchison M, Kleist DM. Review of narrative therapy: research and utility. Fam J 2000;8;61.
  • 23
    Cepeda MD, Richard Chapman C, Nelcy Miranda RN et al. Emotional disclosure through patient narrative may improve pain and well-being: results of a randomized controlled trial in patients with cancer pain. J Pain Symptom Manage 2008;35:623631.
  • 24
    Montazeri A. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res 2008;27:3245.
  • 25
    Frick E, Tyroller M, Panzer M. Anxiety, depression and quality of life of cancer patients undergoing radiation therapy: a cross-sectional study in a community hospital outpatient centre. Eur J Cancer Care (Engl) 2007;16:130136.
  • 26
    Frost MH, Sloan JA. Quality of life measurements: a soft outcome-or is it? Am J Manag Care 2002;8:S574S579.
  • 27
    Bernard RB, Viljoen G. Depressive disorders in out-patient oncology setting: prevalene, assesment and managenment. Psycho-Oncology 1998;7:112120.
  • 28
    Okamura M, Yamawaki S, Akechi T. Psychiatric disorders following first breast cancer recurrence: prevalence, associated factors and relationship to quality of life. Jpn J Clin Oncol 2005;35(6):302309.
  • 29
    Golden-Kreutz DM, Thornton LM, Wells-Di GS et al. Traumatic stress, perceived global stress, and life events: prospectively predicting quality of life in breast cancer patients. Health Psychol 2005;24:288296.
  • 30
    Cipriani A. Comparative efficacy and acceptability of 12 new-generation antidepressant: a multiple-treatments meta-analysis. Lancet 2009;373(9665):746758.
  • 31
    Kennedy SH, Henning FA. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis. J Psychiatr Neurosci 2006;31(2):122131.
  • 32
    Cipriani A. Escitalopram versus other antidepressive agents for depression (Review). The Cochrane Collaboration. 2009.
  • 33
    Escitalopram in Treating Depression in Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer. June 2009.
  • 34
    Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck cancer patients receiving treatment (PROTECT). Clinical 2009.
  • 35
    Hermans HJ, Hermans E. Self Narratives, the Construction of Meaning in Psychotherapy. Guilford: New York, 1986.
  • 36
    Dimaggio G, Catania S. Strategies for the treatment of dialogical dysfunctions. In HermansHJ DimaggioG The Dialogical Self in Psychotherapy. Brunner-Routledge: New York, 2004.
  • 37
    Sarbin TR. Narrative Psychology. The Storied Nature of Human Nature. Praeger: New York, 1986.
  • 38
    Fernández Liria A, Rodríguez Vega B. La práctica de la Psicoterapia: La Construcción de narrativas terapéuticas., vol. 1. Descleé de Brouwer: Bilbao, 2001.
  • 39
    Fayers PM, Aaronson NK, Bjordal K. EORTC QLQ-C30 Scoring Manual (2d edn). European Organisation for Research and Treatment of Cancer: Brussels, Belgium, 1999.
  • 40
    Aaronson NK, Ahmedzai S, Bergman B et al. The European Organization for research and treatment of cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365376.
  • 41
    Holzner B, Kemmler G, Cella D et al. Normative data for functional assessment of cancer therapy general scale and its use for the interpretation of quality of life scores in cancer survivors. Acta Oncol 2004;43:153160.
  • 42
    Arrarás J, Prujá E, Tejedor M et al. El cuestionario de calidad de vida de la EORTC, QLQ-C30 (versión 2.0). Estudio estadístico de validación para nuestro país con pacientes con cáncer de pulmón. Rev Oncol 1999;1:257263.
  • 43
    Arrarás JI, Illaramendi JJ, Valerdi JJ. El cuestionario de calidad de vida para cáncer de la EORTC, QLQ-C30. Statistical validation study with a spanish sample. Rev Psicol Salud 1995;7:1331.
  • 44
    Herrero MJ, Blanch J, Peri JM, De Pablo J, Pintor L, Bulbena A. A validation study of the Hospital Anxiety and Depression scale (HADS) in a spanish population. Gen Hosp Psychiatry 2003;25:277283.
  • 45
    Lopéz-Roig S, Terol MC, Neipp MC et al. Assessing anxiety and depression with HAD scale in a cancer spanish population: a preliminary validation study. 4th International Congress of Psycho-Oncology. Hamburg, Germany, September 1998.
  • 46
    Zigmond AS, Snaith RP. The Hospital Anxiety and Depression scale. Acta Psychiatr Scand 1983;67:361370.
  • 47
    Mitchell A, Meader N, Symond P. Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative setting: a meta-analysis. J Affect Disord 2010, DOI: 10.1016/J.JAD.2010.01.067.
  • 48
    Alexander S, Palmer C. Evaluation of screening instruments for depression and anxiety in breast cancer survivors. Breast Cancer Res Treat 2010;122(2):573578.
  • 49
    Fallowfield L, Ratcliffe D, Jenkins V. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 2001;84(8):10111015.
  • 50
    Schwartz CE, Bode R, Repucci N, Becker J, Sprangers MA, Fayers PM. The clinical significance of adaptation to changing health: a meta-analysis of response shift. Qual Life Res 2006;15:15331550.
  • 51
    Lindbland AK, Ring L, Glimelius B, Hansson M. Focus on the individual: quality of life assessments in oncology. Acta Oncol 2002;41:507516.
  • 52
    Moher D, Schulz K, Altman D. The consort statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:11911194.